Clinical trial
Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience
NCT06655935 is registered in ClinicalTrials.gov with Egyptian Biomedical Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience
- Lead sponsor
- Egyptian Biomedical Research Network
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- June 30, 2023
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial septal defect (asd)